Physician

Mohammed Abid Razvi, M.D.

According to 2025 Medicare claims, Mohammed Razvi, M.D. (NPI: 1750728549) practices interventional radiology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is CHESAPEAKE UROLOGY ASSOCIATES, LLC (NPI: 1609823004; TIN: 522146172) and primary practice location at 21204-2600.

Razvi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 713 traditional Medicare patients, billed 38,114 HCPCS/CPT codes, and received $4,497,635 in Medicare payments. The top billing code was 36247 (Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch). Part D data shows 1,615 prescription claims across 408 beneficiaries totaling $5,730 in drug costs, led by Methylprednisolone (Methylprednisolone). Open Payments data shows 5 records totaling $304. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $22,738 to $4,497,635. Similarly, Part D prescription costs have moved sharply higher in recent years, from $988 to $5,730. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	189	363	$22,738
2020	338	838	$57,599
2021	314	771	$55,666
2022	249	9,846	$952,420
2023	561	45,060	$3,547,428
2024	713	38,114	$4,497,635

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	11	$988
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	14	$101
2021	N/R	N/R	N/R
2022	52	220	$1,551
2023	234	922	$5,966
2024	408	1,615	$5,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36247	Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch	346	699	$588
99441	Telephone medical discussion with physician, 5-10 minutes	380	448	$44
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	378	383	$42
76937	Ultrasonic guidance for blood vessel access	349	354	$32
99153	Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes	377	1,144	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Methylprednisolone	Methylprednisolone	402	2,415	$2,767
Ibuprofen	Ibuprofen	345	2,411	$870
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	373	1,221	$715
Famotidine	Famotidine	381	2,671	$565
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	208	$205

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$304	PROGENICS PHARMACEUTICALS, INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohammed Abid Razvi, M.D.?

Tedicare shows public-source Medicare data for Mohammed Abid Razvi, M.D. (NPI 1750728549), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohammed Abid Razvi, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohammed Abid Razvi, M.D.?

Mohammed Abid Razvi, M.D. is linked to CHESAPEAKE UROLOGY ASSOCIATES, LLC (billing NPI 1609823004) in the available physician profile data.

Does Mohammed Abid Razvi, M.D. have Open Payments data?

Mohammed Abid Razvi, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.